rs143198263

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_020822.3(KCNT1):​c.2994G>A​(p.Leu998Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00112 in 1,572,976 control chromosomes in the GnomAD database, including 8 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. L998L) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0010 ( 1 hom., cov: 31)
Exomes 𝑓: 0.0011 ( 7 hom. )

Consequence

KCNT1
NM_020822.3 synonymous

Scores

3

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: -0.647

Publications

2 publications found
Variant links:
Genes affected
KCNT1 (HGNC:18865): (potassium sodium-activated channel subfamily T member 1) Potassium channels represent the most complex class of voltage-gated ion channels from both functional and structural standpoints. Their diverse functions include regulating neurotransmitter release, heart rate, insulin secretion, neuronal excitability, epithelial electrolyte transport, smooth muscle contraction, and cell volume. This gene encodes a sodium-activated potassium channel subunit which is thought to function in ion conductance and developmental signaling pathways. Mutations in this gene cause the early-onset epileptic disorders, malignant migrating partial seizures of infancy and autosomal dominant nocturnal frontal lobe epilepsy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2012]
KCNT1 Gene-Disease associations (from GenCC):
  • childhood-onset epilepsy syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • developmental and epileptic encephalopathy, 14
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
  • malignant migrating partial seizures of infancy
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
  • autosomal dominant nocturnal frontal lobe epilepsy 5
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • autosomal dominant nocturnal frontal lobe epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_020822.3, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.56).
BP6
Variant 9-135784585-G-A is Benign according to our data. Variant chr9-135784585-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 195982.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.647 with no splicing effect.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.001 (147/146908) while in subpopulation AMR AF = 0.00226 (33/14580). AF 95% confidence interval is 0.00166. There are 1 homozygotes in GnomAd4. There are 65 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High AC in GnomAd4 at 147 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_020822.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KCNT1
NM_020822.3
MANE Select
c.2994G>Ap.Leu998Leu
synonymous
Exon 26 of 31NP_065873.2Q5JUK3-3
KCNT1
NM_001272003.2
c.2859G>Ap.Leu953Leu
synonymous
Exon 25 of 31NP_001258932.1Q5JUK3-4

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KCNT1
ENST00000371757.7
TSL:1 MANE Select
c.2994G>Ap.Leu998Leu
synonymous
Exon 26 of 31ENSP00000360822.2Q5JUK3-3
KCNT1
ENST00000460750.5
TSL:1
n.*2604G>A
non_coding_transcript_exon
Exon 26 of 32ENSP00000418777.1F8WC49
KCNT1
ENST00000460750.5
TSL:1
n.*2604G>A
3_prime_UTR
Exon 26 of 32ENSP00000418777.1F8WC49

Frequencies

GnomAD3 genomes
AF:
0.00100
AC:
147
AN:
146784
Hom.:
1
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.000278
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00227
Gnomad ASJ
AF:
0.000875
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00133
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0367
Gnomad NFE
AF:
0.00110
Gnomad OTH
AF:
0.00446
GnomAD2 exomes
AF:
0.00129
AC:
313
AN:
243214
AF XY:
0.00133
show subpopulations
Gnomad AFR exome
AF:
0.0000652
Gnomad AMR exome
AF:
0.00243
Gnomad ASJ exome
AF:
0.00132
Gnomad EAS exome
AF:
0.0000551
Gnomad FIN exome
AF:
0.0000490
Gnomad NFE exome
AF:
0.00156
Gnomad OTH exome
AF:
0.00373
GnomAD4 exome
AF:
0.00113
AC:
1612
AN:
1426068
Hom.:
7
Cov.:
34
AF XY:
0.00113
AC XY:
800
AN XY:
709094
show subpopulations
African (AFR)
AF:
0.00109
AC:
35
AN:
31968
American (AMR)
AF:
0.00275
AC:
120
AN:
43712
Ashkenazi Jewish (ASJ)
AF:
0.000838
AC:
21
AN:
25054
East Asian (EAS)
AF:
0.0000269
AC:
1
AN:
37192
South Asian (SAS)
AF:
0.000842
AC:
72
AN:
85546
European-Finnish (FIN)
AF:
0.000103
AC:
5
AN:
48626
Middle Eastern (MID)
AF:
0.0249
AC:
111
AN:
4462
European-Non Finnish (NFE)
AF:
0.000995
AC:
1086
AN:
1091482
Other (OTH)
AF:
0.00277
AC:
161
AN:
58026
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
80
160
241
321
401
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
38
76
114
152
190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00100
AC:
147
AN:
146908
Hom.:
1
Cov.:
31
AF XY:
0.000910
AC XY:
65
AN XY:
71390
show subpopulations
African (AFR)
AF:
0.000277
AC:
11
AN:
39714
American (AMR)
AF:
0.00226
AC:
33
AN:
14580
Ashkenazi Jewish (ASJ)
AF:
0.000875
AC:
3
AN:
3428
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4778
South Asian (SAS)
AF:
0.00133
AC:
6
AN:
4512
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
9546
Middle Eastern (MID)
AF:
0.0393
AC:
11
AN:
280
European-Non Finnish (NFE)
AF:
0.00110
AC:
74
AN:
67144
Other (OTH)
AF:
0.00442
AC:
9
AN:
2038
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
6
13
19
26
32
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00147
Hom.:
0
Bravo
AF:
0.00151
Asia WGS
AF:
0.00115
AC:
4
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
6
not provided (6)
-
-
1
Autosomal dominant nocturnal frontal lobe epilepsy 5 (1)
-
-
1
Developmental and epileptic encephalopathy, 14 (1)
-
-
1
Developmental and epileptic encephalopathy, 14;C3554306:Autosomal dominant nocturnal frontal lobe epilepsy 5 (1)
-
-
1
Inborn genetic diseases (1)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.56
CADD
Benign
4.9
DANN
Benign
0.77
PhyloP100
-0.65
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs143198263;
hg19: chr9-138676431;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.